The U.S. Food and Drug Administration has authorized a new monoclonal antibody treatment for COVID-19. ABC News reports the drug, called bebtelovimab from Eli Lilly, is a monoclonal therapy meant for COVID-19 patients as young as 12 who are at … [Read more...]